DATAPHARM A/S: Financial statements 2020
CVR: 72323211
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
DATAPHARM A/S (CVR 72323211) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK 304,908 compared with DKK -2,553,033 the year before. Equity in the 2020 report amounted to DKK 8,295,615. The solvency ratio was 73.7%.
- Profit/Loss
- DKK 304,908
- Equity
- DKK 8,295,615
- Total Assets
- DKK 11,261,291
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | - | 305 t. | 8.3 mio. | 0 |
| 2019 | - | - | -2.6 mio. | 8 mio. | - |
| 2018 | - | - | -2.5 mio. | 10.5 mio. | - |
| 2017 | - | 1.2 mio. | -2.5 mio. | 13 mio. | 1 |
| 2016 | - | 1.6 mio. | -2.3 mio. | 15.5 mio. | - |
Official annual report
How creditworthy is DATAPHARM A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
DATAPHARM A/S has published its annual report for 2019. The net result was DKK -2,553,033.
About DATAPHARM A/S
DATAPHARM A/S is a Danish company of the type Aktieselskab based in København K, founded in 1983. The company is registered under the industry Computerprogrammering. The management consists of Henrik Bruun. The board consists of Dan Asmussen (chair), Dorte Kamp Teglgård, Jonas Arendal Grønskov and Mia Bendix Andersen. The company is owned by D.A. INVEST OG UDVIKLING A/S. The company has 4 employees (2004). In 2025, the company reported a net result of DKK 657,407 compared with DKK 650,613 the year before. Equity in the 2025 report amounted to DKK 11,750,274.